Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.40
+0.04503.33%
Volume:27.62K
Turnover:37.55K
Market Cap:82.95M
PE:-0.38
High:1.40
Open:1.33
Low:1.32
Close:1.35
Loading ...

IGM Biosciences Inc : Bmo Initiates Coverage With Outperform Rating; Price Target $21

THOMSON REUTERS
·
06 Dec 2024

IGM Biosciences Initiated at Outperform by BMO Capital

Dow Jones
·
06 Dec 2024

IGM Biosciences initiated with an Outperform at BMO Capital

TIPRANKS
·
06 Dec 2024

IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip

Simply Wall St.
·
12 Nov 2024

Stock Track | IGM Biosciences Soars After Bullish Analyst Actions

Stock Track
·
11 Nov 2024

IGM Biosciences price target raised to $27 from $25 at Stifel

TIPRANKS
·
11 Nov 2024

RBC Capital Reaffirms Their Buy Rating on IGM Biosciences (IGMS)

TIPRANKS
·
11 Nov 2024

IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
10 Nov 2024

Cautious Outlook for IGM Biosciences Amid Delayed Data and Financial Adjustments

TIPRANKS
·
09 Nov 2024

Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development

TIPRANKS
·
09 Nov 2024

IGM Biosciences Shifts Focus to Autoimmunity

TIPRANKS
·
09 Nov 2024

IGM Biosciences Inc expected to post a loss of 80 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
08 Nov 2024

IGM Biosciences Q3 2024 GAAP EPS $(1.01) Misses $(0.80) Estimate, Sales $516.000K Beat $267.222K Estimate

Benzinga
·
08 Nov 2024

BRIEF-IGM Biosciences Announces Q3 2024 Financial Results And Provides Corporate Update

Reuters
·
08 Nov 2024

IGM Biosciences reports Q3 EPS ($1.01), consensus (80c)

TIPRANKS
·
08 Nov 2024